What Is the Optimum Duration of Tamoxifen Adjuvant Therapy?
نویسنده
چکیده
Finally, there are fascinating biologic reasons to address this issue further. In essence, our understanding of the mechanism of action of tamoxifen and other hormonal agents is changing. Initial theories suggested these agent were cytostatic and essentially acted by "freezing" cells in the early G1 phase of the cell cycle. Thus, it was logical to hypothesize that it may be necessary to administer adjuvant tamoxifen indefinitely to keep the breast cancer cell frozen in the early G 1 phase to prevent tumor
منابع مشابه
مقایسه اثرات تاموکسیفن در بروز سنگهای صفراوی در بیماران زن مبتلا به کانسر پستان
Background & Aims: Tamoxifen is used in breast cancer as adjuvant hormonal therapy. Some studies have found effect of tamoxifen on bile components and gallstone formation. The purpose of the study was to find out the association between tamoxifen use in patient with breast cancer and gallstone formation. Materials & Methods: 780 patient with breast cancer who had undergone surgery in 3 hospita...
متن کاملDefining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer.
BACKGROUND Over the past few years, data have been published concerning the relative efficacy and safety profiles of tamoxifen and the aromatase inhibitors (AIs) in the adjuvant therapy setting for women with early hormone receptor-positive breast cancer. Recently, debate has centred around trials which have studied primary tamoxifen and AI therapy, switching and sequencing strategies and exten...
متن کاملSonohysterography for evaluation of endometrial abnormalities in breast cancer patients under tamoxifen therapy
Introduction: Tamoxifen may have secondary adverse effects on the endometrium. The aim of this study was to investigate the endometrial evaluation in women with breast cancer under tamoxifen therapy with Saline infusion Sonohysterography (SIS). Materials and Methods: This cross-sectional study was performed on 40 breast cancer patients under adjutant tamoxifen (20 mg/day for at least 6 months) ...
متن کاملAdjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.
PURPOSE To update the ASCO clinical practice guideline on adjuvant endocrine therapy on the basis of emerging data on the optimal duration of treatment, particularly adjuvant tamoxifen. METHODS ASCO convened the Update Committee and conducted a systematic review of randomized clinical trials from January 2009 to June 2013 and analyzed three historical trials. Guideline recommendations were ba...
متن کاملAdjuvant endocrine therapy for breast cancer.
Endocrine therapy is a critical part of adjuvant therapy in women with hormone receptor-positive breast cancer, and has been shown to reduce the risk of recurrence and death from breast cancer. For decades, 5 years of tamoxifen has been the standard treatment. For premenopausal women, it remains so, and we await the results of ongoing trials to define the role of ovarian suppression or ablation...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Cancer control : journal of the Moffitt Cancer Center
دوره 4 3 Suppl 1 شماره
صفحات -
تاریخ انتشار 1997